Patents by Inventor Warren C. LAU

Warren C. LAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
    Publication number: 20240041868
    Abstract: The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    Type: Application
    Filed: June 2, 2023
    Publication date: February 8, 2024
    Inventor: Warren C. LAU
  • Neuroreceptor compositions and methods of use
    Patent number: 11760788
    Abstract: Compositions and methods for the treatment of neurological disorders whereby vectors contain codon-optimized nucleic acids for expression in humans, encoding a human dopamine receptor D1 protein, a human 5-Hydroxytryptamine receptor 4 protein, and a human G-protein coupled receptor 139).
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: September 19, 2023
    Assignee: Pathways Neuro Pharma, Inc.
    Inventors: Warren C. Lau, Brad Thompson
  • Methods, compositions, and uses of novel FYN kinase inhibitors
    Patent number: 11701353
    Abstract: The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: July 18, 2023
    Assignee: Pathways Neuro Pharma, Inc.
    Inventor: Warren C. Lau
  • NEURORECEPTOR COMPOSITIONS AND METHODS OF USE
    Publication number: 20220281952
    Abstract: The present disclosure provides compositions and methods for the treatment of neurological disorders.
    Type: Application
    Filed: March 2, 2021
    Publication date: September 8, 2022
    Applicant: Pathways Neuro Pharma, Inc.
    Inventors: Warren C. LAU, Brad THOMPSON
  • Gene Therapy for Addiction Disorders
    Publication number: 20220152222
    Abstract: The present invention encompasses treatments for neurologic disorders with recombinant vims vectors encoding G-protein coupled receptors. In particular, the invention is directed to the treatment of addiction disorders including but not limited to alcohol addiction and opiate addiction.
    Type: Application
    Filed: February 27, 2020
    Publication date: May 19, 2022
    Applicant: PATHWAYS NEURO PHARMA, INC.
    Inventors: Warren C. LAU, Brad THOMPSON
  • Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
    Publication number: 20210030753
    Abstract: The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    Type: Application
    Filed: June 9, 2020
    Publication date: February 4, 2021
    Inventor: Warren C. Lau
  • Methods, compositions, and uses of novel Fyn kinase inhibitors
    Patent number: 10688093
    Abstract: The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: June 23, 2020
    Inventor: Warren C. Lau
  • Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
    Publication number: 20180250297
    Abstract: The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    Type: Application
    Filed: September 8, 2016
    Publication date: September 6, 2018
    Inventor: Warren C. LAU